Description
This episode explores key aspects of intriguing intersection of autoimmune liver diseases, such as their distinctive presentations in childhood and adulthood and the influence of inflammatory bowel disease on liver disease phenotypes. The speakers also examines the benefits and risks associated with immunosuppressive treatments in managing these complex conditions.
Faculty
- Palak Trivedi (Moderator)
- Amanda Ricciuto (Faculty)
- Marianne Samyn (Faculty)
- Christoph Schramm (Faculty)
This EASL Studio is supported by Chemomab Therapeutics. EASL has received no input from Chemomab Therapeutics with regards to the content of this programme.
Related episodes
- EASL Studio S5E4: PBC: the itch we need to scratch
- EASL Studio from EASL Congress 2023: Challenges and opportunities for patients with PBC: Highlights from EASL Congress 2023
- EASL Studio S3E3: Primary biliary cholangitis: a look at the future landscape of therapy for patients
ℹ️ Please click here to watch this EASL Studio episode.
